Drygin Studios emerged in the gaming scene with "Bio Inc. - Biomedical Plague" in 2015. This title received positive reception for its unique blend of strategy and simulation, allowing players to create and manage diseases, which sparked interest in the medical simulation genre. The company's dedication to innovative gameplay mechanics is evident in titles such as "Bio Inc. Redemption" and "Bio Inc. Nemesis - Plague Doc."

Specializing in strategy and simulation genres, Drygin Studios has developed games for platforms including PC and mobile devices. Their work on the "Bio Inc." series showcased unique features such as real-time disease management and player-driven narratives, influencing trends in simulation gaming.

The publisher has achieved significant milestones such as the successful launch of multiple titles in the "Bio Inc." series, which have collectively garnered millions of downloads. Their partnership with various mobile platforms has expanded their market reach significantly.

Drygin Studios' portfolio reflects a commitment to delivering quality gaming experiences. Their contributions have resonated with players and critics alike, earning recognition for high ratings and engaging gameplay.

Drygin Studios continues to shape the simulation genre with upcoming projects like "Battle Bros - Tower Defense," demonstrating their ongoing influence in the industry.